Moderna will produce dozens of mRNA vaccines, including cancer vaccine, at Quebec facility

Moderna president Steven Hoge answered reporters' questions at a groundbreaking ceremony at the future site of Moderna’s mRNA vaccine facility in Laval, Quebec, on Nov 7, 2022. The factory will be completed by 2024 at the earliest and is expected to be able to produce up to 100 million doses of mRNA vaccines per year.